4D Molecular Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+4.64%
vs ±30.9% implied · ×0.15
shaded = implied · ▲▼ = realized
Fund move
Fund move
No thesis.
4D Molecular Therapeutics, Inc.
11.98
Linked news
News| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Jupiter TopcoJupiter Topco | $76.5M | 9.82% | — | |
| 2 | RA Capital ManagementRA Capital Management | $67.2M | 8.63% | 0.00% | |
| 3 | BlackRockBlackRockindex-like | $60.5M | 7.77% | +9.67% | |
| 4 | Goldman Sachs GroupGoldman Sachs | $56.6M | 7.28% | +1.27% | |
| 5 | NovoNovo | $43.2M | 5.55% | −11.00% | |
| 6 | State StreetState Streetindex-like | $38.7M | 4.97% | +7.51% | |
| 7 | BVFBVF | $38.3M | 4.92% | 0.00% | |
| 8 | T. Rowe Price Investment ManagementT. Rowe Price | $33.4M | 4.29% | new | |
| 9 | Adage Capital Partners GPAdage Capital Partners GP | $29.9M | 3.84% | +40.12% | |
| 10 | Trails Edge Capital PartnersTrails Edge Capital Partners | $29.6M | 3.81% | +70.99% | |
| 11 | Vanguard Capital ManagementVanguardindex-like | $27.9M | 3.59% | −4.40% | |
| 12 | Armistice CapitalArmistice Capital | $26.6M | 3.42% | 0.00% | |
| 13 | Geode Capital ManagementGeodeindex-like | $15.0M | 1.93% | +5.92% | |
| 14 | Bank of AmericaBank of America | $14.9M | 1.91% | +15.04% | |
| 15 | Evergreen Quality Fund GPEvergreen Quality Fund GP | $12.7M | 1.63% | 0.00% | |
| 16 | Parkman Healthcare PartnersParkman Healthcare Partners | $12.6M | 1.62% | +81.44% | |
| 17 | Citadel AdvisorsCitadel | $12.0M | 1.54% | +184.20% | |
| 18 | Dimensional Fund AdvisorsDimensional | $9.7M | 1.25% | +39.79% | |
| 19 | Deutsche Bank AG\Deutsche Bank AG\ | $9.5M | 1.21% | +0.41% | |
| 20 | Renaissance TechnologiesRenaissance Technologies | $8.2M | 1.05% | +6.28% | |
| 21 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $7.7M | 0.99% | +4.33% | |
| 22 | Diadema PartnersDiadema Partners | $7.6M | 0.98% | new | |
| 23 | Northern TrustNorthern Trustindex-like | $7.5M | 0.96% | +64.58% | |
| 24 | Acuta Capital PartnersAcuta Capital Partners | $6.8M | 0.87% | new | |
| 25 | NuveenNuveenindex-like | $6.7M | 0.86% | −10.45% |
158 managers report $778.5M of 4D Molecular Therapeutics on form 13F for the quarter ended Jun 30 '26. 20 of them hold 80% of it; Jupiter Topco is largest at 9.82%.
No implied move.
No implied move.
Expected move
No implied move.